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Hypoxia-inducible gene domain 1 (HIGD1) proteins are
small integral membrane proteins, conserved from bacteria to
humans, that associate with oxidative phosphorylation super-
complexes. Using yeast as a model organism, we have shown
previously that its two HIGD1 proteins, Rcf1 and Rcf2, are
required for the generation and maintenance of a normal mem-
brane potential () across the inner mitochondrial membrane
(IMM). We postulated that the lower  observed in the
absence of the HIGD1 proteins may be due to decreased proton
pumping by complex IV (CIV) or enhanced leak of protons
across the IMM. Here we measured the  generated by com-
plex III (CIII) to discriminate between these possibilities. First,
we found that the decreased  observed in the absence of the
HIGD1 proteins cannot be due to decreased proton pumping by
CIV because CIII, operating alone, also exhibited a decreased
 when HIGD1 proteins were absent. Because CIII can nei-
ther lower its pumping stoichiometry nor transfer protons com-
pletely across the IMM, this result indicates that HIGD1 protein
ablation enhances proton leak across the IMM. Second, we dem-
onstrate that this proton leak occurs through CIV because 
generation by CIII is restored when CIV is removed from the
cell. Third, the proton leak appeared to take place through an
inactive population of CIV that accumulates when HIGD1 pro-
teins are absent. We conclude that HIGD1 proteins in yeast pre-
vent CIV inactivation, likely by preventing the loss of lipids
bound within the Cox3 protein of CIV.
The yeast HIGD1 proteins Rcf1 and Rcf2 are small integral
membrane proteins in the inner mitochondrial membrane
(IMM)2 (1–6). Rcf1, but not Rcf2, is necessary for normal accu-
mulation of complex IV and, therefore, for normal accumula-
tion of the yeast CIII2–CIV2 supercomplex (7, 8). Rcf1 acts an
assembly factor for CIV, specifically for Cox3, one of the three
subunits of the catalytic core of CIV (1, 7). Cox3 is a V-shaped
membrane protein, with two hinged transmembrane domains
forming an open cleft in the middle (9 –12) (Fig. 1A). In fully
assembled CIV, the back wall of the Cox3 cleft is a transmem-
brane surface of Cox1, the central subunit of CIV, whereas the
front of the cleft is open to the lipid bilayer. Within the cleft,
conserved residues bind up to five phospholipids in specific
orientations (9 –11, 13) (Fig. 1A). Lipid binding interactions are
critical for the binding of Cox3 to Cox1 (14). In its assembly
role, Rcf1 binds to newly synthesized Cox3 prior to assembly of
Cox3 into CIV (1, 7). Given that lipid binding by Cox3 is
required for its native structure and for its assembly into CIV, it
seems likely that Rcf1 binds to Cox3 to facilitate the process of
lipid insertion (8). A recent structure shows that the transmem-
brane region of Rcf1 has a V shape similar to that of Cox3 (Fig.
1A) (15). In fact, the transmembrane domain of Rcf1 can be
superimposed onto the final structure of Cox3, a position that
would be consistent with lipid delivery by Rcf1 into the cleft of
Cox3 or with Rcf stabilizing the V-shape of Cox3 during lipid
binding.
In addition to the role of Rcf1 in CIV assembly, both HIGD1
proteins are necessary for fully assembled CIV to generate and
maintain a normal membrane potential in isolated mitochon-
dria (8). In the absence of both HIGD1 proteins, yeast mito-
chondria showed a 33% decrease in membrane potential ()
during electron transfer (ET) through CIV (8). It is important to
note that this decrease in  is independent of (i.e. not due to)
the reduced accumulation of CIV that occurs in the absence of
Rcf1. Decreases in  were seen in the absence of only Rcf1 or
only Rcf2 (8). Both of the HIGD1 proteins play a role in main-
taining , and their contributions are additive.
Both yeast HIGD1 proteins bind directly to fully assembled
CIV (1–3). The proteins do not bind as subunits. Rather, their
interactions with CIV are dynamic and substoichiometric and
appear to occur via Cox3 (1, 7). We have hypothesized that the
HIGD1 proteins may function to maintain normal lipid binding
in Cox3 of fully assembled CIV, e.g. by facilitating lipid replace-
ment into Cox3 from the bilayer (8). Because the HIGD1 pro-
teins appear linked to Cox3, and functional Cox3 is required for
normal proton pumping by CIV (16 –18), we proposed (8) that
the lower  generated by CIV could arise from decreased H
pumping by CIV. However, we could not rule out enhanced
proton leak through CIV or some other component of the
IMM.
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Here we measured the generation of  by CIII of yeast in
the presence or absence of the HIGD1 proteins and in the pres-
ence or absence of CIV to more precisely define the function of
the yeast HIGD1 proteins. The data support the proposal that
CIV is the dysfunctional component responsible for the lower
 of mitochondria in the absence of the HIGD1 proteins.
However, the data are inconsistent with the proposal that the
lower  is due to decreased proton pumping by CIV. Rather,
a population of inactive CIV appears to be capable of proton
backleak across the IMM. Because disturbed lipid binding in
Cox3 is known to enhance the inactivation of CIV (14), the
finding that the HIGD1 proteins function to prevent the inac-
tivation of CIV is entirely consistent with their proposed role in
maintaining the lipid component of Cox3.
Results
The lower  of mitochondria lacking HIGD1 proteins
appears to be due to proton leak through the IMM
Neither the content of CIII (8) nor its activity is affected by
the absence of both HIGD1 proteins (rcf1;rcf2 mitochon-
dria; Fig. 2, A and B). These findings, along with the known
enzymology of CIII, allowed us to use CIII to distinguish
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party– hosted site.
Figure 1. A, structure of Cox3 of CIV of yeast and bovine mitochondria and
structure of the transmembrane domain of Rcf1. a, a structure of yeast Cox3
(green) and Cox1 (gray) at 3.35 Å taken from a cryo-EM structure of the III2–IV2
supercomplex of S. cerevisiae (PDB code 6HU9) (11). Although the membrane
is not shown, both Cox3 and Cox1 are almost entirely within the IMM. Three
phospholipids (blue) are resolved in the cleft of Cox3 in this structure. Heme
a3 of the active site in Cox1 is shown in purple. b, transmembrane domain of
yeast Rcf1 taken from the solution structure of Zhou et al. (15) (PDB code
5NF8). Similar to Cox3, the TM helices of Rcf1 form a V shape, connected by a
hinge region that extends slightly into the matrix. Although Rcf1 is smaller
than Cox3, its V shape can be superimposed atop the V shape of Cox3, sug-
gesting a possible binding interaction. c, a structure of bovine Cox3 (yellow)
and Cox1 (gray) at 1.8 –1.9 Å taken from an X-ray structure of bovine CIV (PDB
code 2EIL) (9). Five Cox3 lipids are resolved in this structure, four phosphati-
dylglycerol (cyan) within the cleft plus one cardiolipin (pink) that binds at the
entrance to the cleft. Heme a3 of the active site in Cox1 is shown in blue. The
graphics were generated using YASARA (Yet Another Scientific Artificial Real-
ity Application; http://www.yasara.org/ (44)).4 B, diagrams showing the elec-
trogenic charge movements associated with full catalytic cycles of CIII and
CIV. In one catalytic cycle of CIII, two QH2 are oxidized at Qo, one Q is reduced
at Qi, and two soluble cytochromes c are reduced by heme c1. In one cycle, CIII
generates  by electrogenic release of two H from Qo (two more H
 are
released from Qo, but these are charge-compensated by e
 release from Qo
and are therefore nonelectrogenic), electrogenic transfer of two e from Qo
to Qi, and electrogenic uptake of two H
 to Qi. In one catalytic cycle of CIV,
four e are transferred toward the negative side of the IMM (dashed line),
whereas 4 H are transferred toward the positive side of the IMM (solid line),
all to the O2 reduction site in the transmembrane domain of Cox1. Here the
negative and positive charges annihilate (creating neutral H2O), resulting in
the equivalent of four transmembrane charge translocations. Simultaneous
with these partial charge transfers, the exergonic energy of O2 reduction is
harnessed to pump four H completely from the negative side to the positive
side of the IMM, resulting in four more charge separations. Note that the
proton pumping activity of CIV requires a transmembrane pathway for H. In
contrast, there is no pathway for H to completely cross the membrane
through CIII. Proton backleak (dotted line) and the gate in CIV are discussed in
the text.
Figure 2. The content and activity of CIII in yeast mitochondria and the
decreased membrane potential generated by CIII in mitochondria lack-
ing the HIGD1 proteins. A, the content of CIII in various strains was deter-
mined from visible spectra (Fig. S1) as described under “Experimental proce-
dures.” B, the uncontrolled ET activity of CIII (1 mM NADH to 3 mM ferricyanide)
measured in intact mitochondria in the presence of uncoupler (10 M CCCP).
C and D, maximum percentage of safranin uptake (maximum fluorescence
quenching) during continuous state 2 (no ADP) ET through CIII in intact mito-
chondria (1 mM NADH to 3 mM ferricyanide) (C) and the same during ET from
20 mM ethanol to 1 mM ferricyanide (D). E and F, controlled turnover numbers
(e per second per CIII), measured under the same state 2 conditions, for ET
from NADH to ferricyanide (E) and for ET from ethanol to ferricyanide (F).
Significance to the WT control was determined by the unpaired Student t test.
B, **, p  0.0021. C–F, *, p  0.0304; **, p  0.0026; ****, p  0.0001.
HIGD1 proteins prevent proton leak through CIV
17670 J. Biol. Chem. (2019) 294(46) 17669 –17677
 at M
A
R
Q
U
E
T
T
E
 U
N
IV
 on M
arch 16, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
whether the decreased  characteristic of yeast mitochondria
that lack the HIGD1 proteins (8) is caused by decreased proton
pumping by CIV or by an increased leak for H through the
IMM. As diagrammed in Fig. 1B, the catalytic cycle of CIII
includes the electrogenic transfer of both protons and electrons
within the membrane (19, 20). The mechanism of CIII locks in
its stoichiometry of charge separations, i.e. if CIII of intact mito-
chondria exhibits normal antimycin-sensitive ET activity, then
it is capable of generating a normal . If the lower  of
rcf1;rcf2 mitochondria results from diminished proton
pumping by CIV, then the  developed by CIII, independent
of CIV, should be the same in both rcf1;rcf2 mitochondria
and normal mitochondria. If, however, the lower  of rcf1;
rcf2 mitochondria is due to increased proton leak across the
IMM, the  generated by CIII will be subject to this leak, and
the  generated by CIII will be lower in rcf1;rcf2 mito-
chondria than in normal mitochondria.
The  developed by CIII alone was assayed by measuring
the uptake of the cationic fluorescent dye safranin during
steady-state ET, using NADH or ethanol as electron donors and
ferricyanide as the terminal electron acceptor (see “Experimen-
tal procedures”). Cyanide is present to inhibit CIV. NADH is
oxidized by a peripheral membrane dehydrogenase that trans-
fers the electrons to ubiquinone (21). This NADH dehydroge-
nase does not generate . Fig. 2C shows that CIII, even
though it is present at normal levels and has normal activity
(Fig. 2, A and B), showed an approximate 50% decline in safra-
nin uptake in rcf1;rcf2 mitochondria during ET from NADH
to ferricyanide. A similar result was obtained during the 10-fold
slower rate of steady-state of ET through CIII driven by ethanol,
which generates NADH in vivo as it is oxidized (Fig. 2D). In
both cases, the  generated by CIII ET is completely collapsed
by addition of antimycin A (data not shown), confirming that
antimycin A–sensitive ET through CIII is responsible for 
generation. Because the -generating power of CIII of WT
and CIII of rcf1;rcf2 mitochondria are equal under these
conditions, the lower  in rcf1;rcf2 mitochondria indi-
cated that a proton leak exists somewhere in the IMM of the
mitochondria lacking the HIGD1 proteins.
Comparison of the rates of coupled (controlled) ET and
uncoupled (uncontrolled) ET through CIII provided indepen-
dent confirmation that the  generated by CIII is lower in
intact rcf1;rcf2 mitochondria than in WT mitochondria.
Controlled ET through CIII in intact WT mitochondria (Fig.
2E) is slower than in chemically uncoupled WT mitochondria
(Fig. 2B) because of the inhibition of ET in intact mitochondria
by . Controlled ET through CIII in rcf1;rcf2 mitochon-
dria is also slower than in chemically uncoupled mitochondria
(compare Fig. 2, B and E), but the extent of inhibition of ET by
 is clearly less than that in WT mitochondria. This indicates
that a lower  is generated by CIII ET in intact rcf1;rcf2
mitochondria than in intact WT mitochondria.
CIV is the source of the proton leak in mitochondria lacking
the HIGD1 proteins
Having established the presence of a leak for protons across
the IMM of rcf1;rcf2 mitochondria, the obvious question is,
where is it? Existing evidence suggests that the proton leak seen
in the absence of the HIGD1 proteins occurs through CIV. The
HIGD1 proteins form dynamic associations with CIV (1, 7). In
mitochondria lacking the HIGD1 proteins, CIV generates a
lower-than-normal  (8). Despite these links to CIV, Rcf1 at
least associates with other components in the IMM, particu-
larly the ATP/ADP exchanger proteins (1, 7). Hence, the
absence of the HIGD1 proteins could open a proton leak else-
where in the IMM. We reasoned that if CIV is the source of the
proton leak in rcf1;rcf2 mitochondria, then removing CIV
from the IMM should remove the leak and restore the ability of
CIII to maintain a normal . Complex IV does not assemble
in a yeast strain in which the gene for Cox11, a copper chaper-
one absolutely required for the insertion of CuB into the active
site (22–24), has been deleted (25). The yeast strains cox11
and rcf1;rcf2 were crossed to obtain a triple mutant lacking
Cox11 and the two HIGD1 proteins (rcf1;rcf2;cox11). We
first examined the content and uncontrolled activity (i.e. in the
absence of ) of CIII in cox11 and rcf1;rcf2;cox11 (Fig.
2, A and B). The content of CIII appears to be lower in the
absence of CIV (Fig. 2A). Compared with WT, the uncontrolled
activity of CIII (TN) was 14% lower in the absence of CIV,
although the data did not reach significance (cox11 versus
WT, Fig. 2B). The uncontrolled activity of CIII is significantly
lower than normal (by 43%) in the absence of both CIV and the
HIGD1 proteins (rcf1;rcf2;cox11 versus the WT, Fig. 2B).
The reason for these activity declines are not yet clear. Even
with the lower inherent activity of the pool of CIII in rcf1;
rcf2;cox11 mitochondria, the complex generated signifi-
cantly greater  during controlled ET than CIII in mitochon-
dria that lack the HIGD1 proteins but contain CIV (rcf1;rcf2,
Fig. 3). This result was observed during more rapid NADH-
driven ET through CIII and during the slower ethanol-driven
ET (Fig. 3). Compared with the WT, the removal of CIV
(cox11) lowered the percentage of safranin uptake by up to
Figure 3. The low mitochondrial membrane potential generated by CIII
in the absence of the HIGD1 proteins is restored by further removal of
CIV. Conditions and presentation are as in Fig. 2, C and D. Significance to the
WT controls was determined by unpaired Student t test. *, p  0.02; **, p 
0.0019; ****, p  0.0001.
HIGD1 proteins prevent proton leak through CIV
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10%, perhaps consistent with the lower TN for CIII in the
absence of CIV (Fig. 2B). However, there was no further signif-
icant loss of safranin uptake when the HIGD1 proteins were
removed from cox11 mitochondria (cox11 versus rcf1;
rcf2;cox11, Fig. 3). Despite the unexplained changes in CIII
activity, the data make clear that removing CIV alleviates pro-
ton leak and restores the ability of CIII to maintain . This
strongly favors the hypothesis that CIV is the source of
increased proton leak in the absence of the HIGD1 proteins.
In rcf1;rcf2 mitochondria, the lower-than-normal level of
CIV is associated with a dimer of CIII forming a III2–IV1 super-
complex as opposed to the III2–IV2 supercomplex of WT mito-
chondria (1, 8). The question arises whether this altered asso-
ciation of CIV with CIII is somehow driving proton leak
through CIV, e.g. by altering its structure. This was tested using
mitochondria containing CIV but lacking CIII and then in the
presence or absence of the HIGD1 proteins. Complex III fails to
assemble in yeast mitochondria lacking the gene (cor1) for the
core subunit (26). The cor1 strain was crossed with rcf1;
rcf2 to create a triple mutant lacking CIII and the HIGD1
proteins (rcf1;rcf2;cor1). In the absence of the HIGD1 pro-
teins, the content and the uncontrolled activity of CIV are both
lowered to the same extent whether or not CIII is present (Fig.
4, A and B). Further, decreases in safranin uptake and increases
in controlled ET rates (both indicative of uncoupling) show that
the  in the absence of the HIGD1 proteins is decreased to the
same extent whether CIII is present (WT, rcf1;rcf2) or
absent (cor1, rcf1;rcf2;cor1) (Fig. 4, C and D). We con-
clude that the association of CIV with CIII has no effect on
proton leak through CIV.
Proton leak takes place through inactive CIV in the IMM
Brzezinski and co-workers (27) have demonstrated that inac-
tive CIV accumulates in the IMM of mitochondria lacking Rcf1
or Rcf2. Suicide inactivation of CIV is a well-studied phenom-
enon (see “Discussion”). Heme a is retained in the inactive
enzyme (28). Because heme a is used to quantitate the amount
of enzyme, a population of CIV that is part active enzyme with
normal activity and part inactive enzyme with no activity will
exhibit an overall lower apparent TN (activity per enzyme).
Indeed, we found that the uncontrolled TN of CIV of strains
lacking Rcf1, Rcf2, or both of the HIGD1 proteins declined pro-
gressively (Fig. 5A). We propose that the apparent TN declines
because of increasing amounts of inactive CIV in this series of
HIGD1 protein deletion strains. Significantly, the ability of
these mitochondria to generate  declines in this same pat-
tern, i.e. WT 	 rcf1 	 rcf2 	 rcf1;rcf2 (Fig. 5B and similar
to that published previously (8)). Hence, in this series of HIGD1
protein deletion mutants, increasing proton leak across the
IMM correlates with increasing amounts of inactivated CIV in
the IMM. This correlation suggests that inactivated CIV is the
source of proton leak.
Further evidence that inactivated CIV is the source of
enhanced proton leak comes from examination of the kinetics
of CIV ET and the concomitant generation of . Suicide inac-
tivation of CIV appears as the exponential loss of activity in a
population of CIV during continuous electron transfer to O2
(28, 29). Such an exponential loss of CIV activity was observed
during continuous ET through CIV in mitochondria from
rcf1;rcf2 cells but not for CIV in mitochondria isolated from
WT cells (Fig. 6A). Hence, the IMMs of isolated rcf1;rcf2
Figure 4. In the absence of the HIGD1 proteins, the content and uncon-
trolled ET activity of CIV are both lowered to the same extent whether or
not CIII is present. Proton leak through CIV is not affected by the association
of CIV with CIII. A, the content of CIV in intact mitochondria was determined
by visible spectroscopy as described under “Experimental procedures.” B, the
uncontrolled turnover number of CIV (e per second per CIV) measured using
broken mitochondria. Broken mitochondria were used to ensure that the
comparisons of CIV activity are not influenced by the differences in mem-
brane potential that would occur in intact mitochondria. C, the membrane
potential (as percentage of safranin uptake) generated by CIV in intact mito-
chondria during state 2 ET through CIV, as described under “Experimental
procedures.” D, state 2 (controlled) turnover numbers of CIV in intact mito-
chondria. Significance to the WT controls was determined by unpaired Stu-
dent t test. A, *, p  0.0327; ***, p  0.0001. B, ****, p  0.0001. C, **, p  0.0048;
***, p  0.001; ****, p  0.0001. D, *, p  0.0421; ***, p  0.0002.
Figure 5. The apparent TN (e per second per CIV) and membrane poten-
tial generated by CIV in normal mitochondria and those lacking Rcf1,
Rcf2, or both HIGD1 proteins. A, uncontrolled TNs of CIV were measured
using broken mitochondria as described under “Experimental procedures.” B,
the membrane potential (as percentage of safranin uptake) generated by CIV,
which was energized by 5 mM ascorbate and 0.1 mM TMPD during state 2 ET.
Significance to the WT controls was determined by unpaired Student t test. A,
*, p  0.0425; ***, p  0.001; ****, p  0.0001. B, ****, p  0.0001.
HIGD1 proteins prevent proton leak through CIV
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mitochondria experience an increase in inactivated CIV during
continuous ET through CIV.
On the same timescale that the population of inactivated
CIV was increasing in mitochondria lacking the HIGD1 pro-
teins, a further exponential loss of  was consistently
observed during continuous ET (Fig. 6B). (Single exponen-
tial kinetics were verified by curve fitting; data not shown.) In
contrast, such a loss of  was not observed in mitochondria
that contained the HIGD1 proteins (Fig. 6C) and did not
show an increase in inactivated CIV during continuous ET
(Fig. 6A). The kinetic traces explained above show that
increasing amounts of inactivated CIV correlate with
increasing proton leak. This strongly suggests that proton
leak takes place through inactivated CIV.
We tested whether the loss of CIV activity (i.e. the ability to
generate ) that occurs during the 2- to 4-min period of the
experiments shown in Fig. 6B is sufficient to cause the observed
decrease in . From the data in Fig. 6A, the activity lost by
CIV of rcf1;rcf2 mitochondria over a 4-min period is 
30%.
Using data (not shown) where we examined how the percentage
of safranin uptake varies with CIV activity during  measure-
ments, we estimate that a 30% loss of ET activity could lead to a
5% decline in the percentage of safranin uptake in experiments
performed as described. However, the data for rcf1;rcf2
mitochondria in Fig. 6B show a 25% decline in the percentage of
safranin uptake over a 4-min period. Hence, we conclude that
the bulk of this  loss during continuous activity cannot be
explained by decreased generation of  because of slowing
ET. Rather, we assign the loss of  during continuous activity
to increasing proton leak.
Both Rcf1 and Rcf2 contribute to the prevention of the inac-
tivation of CIV and to the resulting loss of . As discussed
above, intact mitochondria lacking either one of HIGD1 pro-
teins showed a lower uncontrolled TN than normal mitochon-
dria (Fig. 5A), indicative of a greater content of inactive CIV in
the IMM. The difference in the molecular activities of CIV of
rcf1 and of rcf2 is not large (Fig. 5A), suggesting that Rcf1 and
Rcf2 have a similar capability to prevent the inactivation of CIV.
Their effects are additive, however, because the expression of
both HIGD1 proteins is required for the normal pool of active
CIV proteins. Decreasing  during continuous CIV activity
was also observed in mitochondria lacking only Rcf1 or Rcf2
(Fig. 6D), but to a lesser extent than in mitochondria lacking
both of the HIGD1 proteins.
In rcf1;rcf2 mitochondria, where CIII generates less 
than normal because enhanced proton leak is taking place (Fig.
3), cyanide was present to inhibit all of the active CIV. This rules
out a mechanism in which the absence of the HIGD1 proteins
leads to altered chemistry during the catalytic cycle of CIV to
allow proton leak through active CIV.
Discussion
In a recent study (8), we found that the HIGD1 proteins of
yeast were required for mitochondrial electron transfer
through CIV to generate and maintain a normal membrane
potential. In that report, we proposed that the lower  was
either due to diminished proton pumping by CIV or enhanced
proton leak through some transmembrane component in the
IMM (8). In this study, we determined the following, as detailed
under “Results”: the low  observed in the absence of the
HIGD1 proteins is due to enhanced proton leak through some
component in the IMM, the component that leaks is CIV, and
proton leak appears to take place through a population of inac-
tivated CIV.
These findings allow us to conclude that one function of the
HIGD1 proteins in yeast is to prevent inactivation of CIV dur-
ing electron transfer. Because the prevention of suicide inacti-
vation is a primary function of Cox3 of CIV (14, 30–32), the
conclusion reinforces our proposal that the HIGD1 proteins are
exerting their influence on CIV via Cox3 (1, 7, 8). A proposed
mechanism that links the HIGD1 proteins to CIV inactivation
and to proton leak is described below.
Suicide inactivation of CIV: the role of Cox3 and its bound
lipids
The heme aa3–type cytochrome c oxidases exhibit a tend-
ency to suicide-inactivate, defined as spontaneous, irreversible
loss of activity during catalytic turnover (28 –30). Even though
the probability of inactivation during any single catalytic cycle
is low, an increase in this probability can lower the life span of a
CIV molecule from millions of catalytic cycles to only thou-
sands (14, 33). Inactivation results from ligand rearrangements
at the heme a3–CuB site of O2 reduction in Cox1 during a spe-
cific step in the catalytic cycle (16, 31, 32). One of the three
subunits that comprise the conserved catalytic core of the heme
aa3–type cytochrome c oxidases is Cox3, the lipid-binding
partner of Cox1 (32, 34) (Fig. 1A). A primary function of Cox3 is
to lower the probability (up to 500-fold) that suicide inactiva-
tion will take place during any given catalytic cycle (32), thus
saving the cell from having to frequently resynthesize a major
bioenergetic machine. Cox3 prevents suicide inactivation by
supporting the structure of the heme a3–CuB active site in Cox1
as well as by facilitating proton transfer through a pathway that
delivers protons to the active site as well as to the proton pump
(14, 31). The lipids bound within the central cleft of V-shaped
Figure 6. Kinetics traces of CIV safranin fluorescence and ET in the pres-
ence and absence of the HIGD1 proteins. A, representative traces of O2
consumption by CIV (black line, WT; dashed line, rcf1;rcf2), measured in
broken mitochondria. Continuous ET in broken mitochondria is driven by 5
mM ascorbate, 0.1 mM TMPD, and 20 M horse heart cytochrome c as
described under “Experimental procedures.” Note that, in the absence of the
HIGD1 proteins, continuous ET through CIV leads to an exponential decline in
CIV activity (verified by curve fitting to a single exponential using GraphPad
Prism; data not shown). The traces were collected using broken mitochondria
lacking a . In intact mitochondria lacking the HIGD1 proteins, the concom-
itant decrease in  leads to an increase in the rate of O2 consumption that
offsets and therefore masks the decrease in CIV activity caused by CIV inacti-
vation. B–D, representative traces of safranin fluorescence during continuous
state 2 ET through CIV in intact mitochondria. Continuous ET in intact mito-
chondria is driven by 5 mM ascorbate and 0.1 mM TMPD as described under
“Experimental procedures.” B, black line, rcf1;rcf2; gray line, rcf1;rcf2;
cor1. C, black line, WT; gray line, cor1. D, black line, rcf1; gray line, rcf2.
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Cox3 (Fig. 1A) are essential for its ability to prevent inactivation
(14). The residues that coordinate Cox3’s lipids are conserved
throughout the family of aa3-type cytochrome c oxidases, from
bacteria to yeast to humans. Alteration of lipid position or
occupancy by site-directed mutation of lipid binding residues
in the aa3-type CIV of Rhodobacter sphaeroides decreased the
expected number of catalytic cycles before inactivation 
100-
fold (14).
The HIGD1 proteins function to protect CIV from suicide
inactivation
Several lines of evidence indicate that suicide inactivation of
yeast CIV is more probable in the absence of the HIGD1 pro-
teins. The isolation of CIV from yeast mitochondria lacking
Rcf1 or Rcf2 revealed the presence of inactivated enzyme (27).
In Fig. 5A, the accumulation of inactivated CIV in the IMM is
indicated by a decrease in the apparent TN of CIV (e per
second per CIV) in mitochondria lacking either Rcf1 or Rcf2
and especially in the absence of both HIGD1proteins.
Experimentally, suicide inactivation of CIV appears as the
exponential loss of activity in a population of CIV during con-
tinuous electron transfer (28, 29). This was observed for CIV in
mitochondria lacking the HIGD1 proteins (Fig. 6A). In the
absence of the HIGD1 proteins, continuous ET through CIV
leads to an exponential loss of CIV activity.
Importantly, active-site structural changes that are charac-
teristic of suicide inactivation (28) have been documented in
the CIV that accumulates in yeast mitochondria in the absence
of Rcf1, including altered binding of cyanide in the active site
and a lowered redox potential for heme a3 (35, 36). Thus, the
sum of the evidence suggests that the HIGD1 proteins normally
function to lower the probability of suicide inactivation and
thereby prevent excessive accumulation of suicide-inactivated
CIV.
In its assembly role, Rcf1 binds to newly synthesized Cox3
before Cox3 binds to Cox1 (1, 7). Because Cox3 must attain its
V-shape to dock with Cox1 (Fig. 1A), and the lipids of the cleft
appear to be necessary for this configuration of Cox3, it seems
likely that Rcf1 enhances CIV assembly by facilitating lipid
insertion into Cox3. Even after assembly of CIV, the bound
lipids of Cox3 are in contact with the lipid bilayer (11, 12). Slow
exchange of the bound lipids with membrane lipids may occur,
and disturbed binding of lipids in the cleft of Cox3 has been
shown to promote suicide inactivation (14). We propose that
Rcf1 and Rcf2 form temporary associations with Cox3 of fully
assembled CIV to facilitate the maintenance and/or restoration
of normal lipid binding in the cleft of Cox3. A specific lipid
delivery interaction is consistent with the finding that the lipid
composition of the IMM in the absence of Rcf1 and Rcf2
appears to be unchanged from the WT (7).3
Although our hypothesis of lipid delivery is an extension of
the assembly role proposed for Rcf1 with Cox3, Rcf2 is not
required for CIV assembly. However, Rcf2 does function to
lessen the inactivation of CIV and the resulting proton leak
through CIV (Fig. 5) (8). Thus, we include Rcf2 in our proposal
for HIGD1 protein function with fully assembled CIV. Rcf2 is
proposed to contain a transmembrane domain similar to that of
Rcf1, after a processing event (4).
Suicide-inactivated CIV and proton leak across the IMM
We proposed that increased amounts of inactivated CIV
leads to increased proton leak back across the IMM. Why might
inactivated CIV have such a leak? Proton pumping by CIV
requires a gate that prevents protons from flowing back
through Cox1 to the inner (negative) side of the IMM, i.e. a
device that normally prevents proton backleak (37–39) (Fig.
1B). Proton transfer pathways lead to this gate from the inner
(negative) surface of the IMM and away from this gate to the
outer (positive) surface (Fig. 1B). The structural elements of the
gate are located close to the heme a3–CuB O2 reduction site
(10 –13). Proton leak likely occurs as the active site structural
changes associated with suicide inactivation (28, 32) allow the
nearby proton gate to adopt a conformation suitable for the
backleak of protons across the IMM (Fig. 1B).
Conclusions
The work of this report plus earlier studies (1, 7, 8) elucidate
functions for the HIGD1 proteins of yeast and allow us to begin
to postulate mechanisms. First, Rcf1 functions as an assembly
protein for Cox3 of CIV (1). It seems likely that, by binding to
Cox3, Rcf1 maintains the structure of Cox3 in a conformation
suitable for lipid binding, which, in turn, is necessary for dock-
ing with Cox1 (14). The enhancement of CIV assembly by Rcf1
maintains normal levels of CIV in the IMM and, thereby, nor-
mal levels of the III2–IV2 supercomplex (1, 7, 8). Second, both
Rcf1 and Rcf2 function to maintain normal mitochondrial
membrane potential (1). In this role, we propose that the
HIGD1 proteins prevent suicide inactivation of fully assembled
CIV and the accumulation of inactivated CIV in the IMM. In
turn, this prevents enhanced proton leak across the IMM.
These results are likely to be informative regarding the func-
tion of related proteins in mammalian mitochondria, including
humans. The HIGD1A protein of mammals is related to Rcf1
and Rcf2 of yeast (7). Using fluorescence microscopy, Li et al.
(40) have shown that knockdown of human HIGD1A in cul-
tured cells lowers mitochondrial membrane potential, whereas
overexpression of HIGD1A protects.
Experimental procedures
Saccharomyces cerevisiae strains and growth conditions
All of the yeast strains used in this study (each is denoted here in
bold) have the genotype of WT W303-1A (Mat , leu2, trp1, ura3,
hid3, ade2) plus the following: rcf1 (RCF1::HIS3) (1), rcf2
(RCF2::HIS3) (1), rcf1; rcf2 (RCF1::HIS3, RCF2::KAN) (1),
cox11 (COX11::HIS) (25), rcf1;rcf2;cox11 (COX11::HIS,
RCF1::HIS, RCF2::KAN) (this study), cor1 (COR1::HIS) (26), and
rcf1;rcf2;cor1 (COR1::HIS, RCF1::HIS, RCF2::KAN) (this
study). Generation of the rcf1;rcf2;cox11 and rcf1;rcf2;
cor1 strains was achieved by crossing the respective parent
strains, i.e. rcf1;rcf2 with cox11 or cor1, followed by diploid
selection, sporulation, tetrad dissection, and genotyping of the
resulting tetrad spores. In the case of the rcf1;rcf2;cox11
strain, the initial genetic cross was achieved using a mat version
of the rcf1;rcf2 parent.3 S. Claypool, personal communication.
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All strains were plated on yeast extract/peptone/dextrose
agar using standard protocols at 30 °C. Cells for the isolation of
mitochondria were grown in liquid culture in YP, 2% galactose,
0.5% lactate (YPGal-lac (pH 5.5)). Strains cox11, rcf1;rcf2;
cox11, cor, and rcf1;rcf2;cor1 were weaned from dex-
trose by first growing them in liquid cultures of YPGal-lac con-
taining 1% dextrose and then YPGal-lac containing 0.2%
dextrose before growth in YPGal-lac without dextrose. The
A580 nm at the time of harvest was 1.5–2 for all strains.
Isolation of intact mitochondria
Yeast intact mitochondria were isolated from spheroplasts
by established experimental procedures (41) with modifica-
tions. Briefly, yeast cells (7–36 g) were collected by centrifuga-
tion at 3000  g for 10 min, weighed, and washed once with
100 –200 ml of nanopure water. To make spheroplasts, cells
were suspended at 7 ml/g of cells in 1.2 M sorbitol, 50 mM
HEPES, 1 mM EDTA, and 1 mM DTT (pH 7.4). Zymolase-20T
(Sunrise Science Products) was added at 3 mg/g of cells, and the
cells were shaken for 30 min at 200 rpm at 30 °C or until the
A580 nm was 10 –20% of its value prior to addition of Zymolase.
The resulting spheroplasts were collected by centrifugation at
3000  g for 10 min and then lysed by addition of 2 volumes of
250 mM sucrose, 50 mM HEPES, 1 mM EDTA, and 1 mM PMSF
(pH 7.4). Cell debris was removed by centrifugation for 10 min
at 2000  g at 4 °C. Intact mitochondria were collected by cen-
trifugation at 7000  g for 15 min at 4 °C. The volume of the
pellet was estimated, and the pellet was resuspended in 0.3– 0.5
volumes of 250 mM sucrose, 1 mM EDTA, and 20 mM MOPS
(pH 7.2). Mitochondrial protein concentrations (usually 10 –20
mg/ml) were measured using the Bio-Rad DC Protein Assay.
Aliquots of 30 l of suspended mitochondria were frozen in
liquid nitrogen and stored at 80C. Mitochondrial aliquots
were thawed immediately before use and discarded after 1 h on
ice.
Preparation of broken mitochondria
Aliquots of frozen intact mitochondria, prepared as above,
were pelleted at 10,000  g for 10 min at 4 °C and then resus-
pended in an equal volume of 20 mM Tris (pH 7.4). The suspen-
sion was fast-frozen in liquid nitrogen and then thawed rapidly
for a total of three freeze/thaw cycles. Broken mitochondria
were used immediately.
Spectroscopic determination of the content of CIII and CIV
Intact mitochondria or broken mitochondria (5–10 mg)
were solubilized in 1.1 ml of 50 mM Tris (pH 7.4) plus 2% dode-
cyl maltoside (Anatrace). Proteinase-free RNase-DNase
(Fisher) with 1 mM MgCl2 was added to digest nucleic acids for
10 min at room temperature. The sample was passed through a
10-mm-diameter, 0.2-m pore size, low-protein-binding filter
(Millipore), and a clear solution was obtained by centrifugation
at 10,000  g for 10 min at 4 °C. Sample and reference cuvettes
were filled with 450 l of the solution. Solid sodium dithionite
was added to the sample and solid potassium ferricyanide to the
reference, and difference spectra were collected from 500 –700
nm using a Hitachi U-3000 spectrophotometer. The concentra-
tion of CIV was determined from A at 604 minus 630 nm, with
an extinction coefficient of 26 mM1 cm1. The concentration
of CIII was determined from A at 560 minus 575 nm with an
extinction coefficient of 51.2 mM1 cm1 (for the absorbance of
both the bL and bH hemes) (42).
Complex III activity
CIII activity was measured in a Hitachi U-3000 spectropho-
tometer at 25 °C as the time-dependent reduction of potassium
ferricyanide to colorless ferrocyanide at 420 nm using a mea-
sured extinction coefficient of 1.04 mM1 cm1. For controlled
(coupled) CIII activity, the reaction mixture contained 250 mM
sucrose, 20 mM MOPS, 5 mM KH2PO4, 1 mM MgCl2, 100 M
EDTA, 100 M EGTA, 1 mg/ml defatted BSA, 5 mM KCN, 3 mM
K3Fe(CN)6, and 0.1– 0.2 mg of intact mitochondria (pH 7.2).
The reaction was initiated by addition of NADH to 1 mM or
ethanol to 20 mM. The rate of state 2 (no ADP) ferricyanide
reduction was linear for 1–3 min. Rates of ferricyanide reduc-
tion that were insensitive to 5 M myxothiazol and 5 M anti-
mycin A were subtracted. Uncontrolled (uncoupled) CIII activ-
ity was measured as above, but the mitochondria were
uncoupled with 9 nM valinomycin and 0.4 M CCCP or with 10
M CCCP alone.
Complex IV activity
Complex IV activity was measured at 25 °C as the rate of
oxygen consumption using an Oroboros FluoRespirometer.
Ascorbate and TMPD were used to donate electrons to soluble
cytochrome c. Rates of nonenzymatic reduction of O2 by ascor-
bate/TMPD/cytochrome c were subtracted from all rates
obtained after the addition of mitochondria.
For controlled (coupled) CIV activity, the reaction mixtures
contained 0.6 M mannitol, 20 mM MOPS (pH 7.2), 10 mM
KH2PO4, 5 mM MgCl2, 50 mM KCl, 1 mM EDTA, 100 M EGTA,
2 g/ml catalase, 1 mg/ml defatted BSA, 5 mM ascorbate, 0.1
mM TMPD, and 5 M antimycin A to inhibit CIII. Uncontrolled
(uncoupled) CIV activity was measured as above, but the mito-
chondria were uncoupled with 9 nM valinomycin and 0.4 M
CCCP or with 10 M CCCP alone.
Alternatively, uncontrolled CIV activity was measured using
broken mitochondria in a reaction mixture of 50 mM Tris (pH
7.4), 8 mM KCl, 1 mM EDTA, 2 g/ml catalase, 5 mM ascorbate,
0.1 mM TMPD, and 20 M horse heart cytochrome c at 25 °C.
Reactions were initiated by addition of 0.1– 0.2 mg of broken
mitochondria.
Calculation of TN
Turnover numbers for CIII and CIV were calculated by
dividing the rate of ET, as nanomole e¯ per second, by the
amount of either complex, in nanomoles, to obtain e¯ per sec-
ond per complex.
Measurements of safranin uptake driven by CIII or CIV activity
in intact mitochondria
Using the conditions described above for state 2, controlled
CIII ET in intact mitochondria, fluorescence quenching repre-
senting the uptake of the membrane-permeable, cationic, fluo-
rescent dye safranin O (2 M) (43) was measured using a Jasco
FP8000 fluorimeter (excitation/emission at 520 nm/580 nm) or
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an Oroboros FluoRespirometer (excitation/emission at 485
nm/586 nm). After full quenching of safranin fluorescence (full
development of membrane potential), the addition of uncou-
pler (9 nM valinomycin and 0.4 M CCCP or 10 M CCCP
alone) caused full release of safranin from the matrix. The per-
centage of safranin uptake was calculated as in Strogolova et al.
(8). Safranin uptake driven by CIV activity in intact mitochon-
dria was measured by similar experimental procedures, as
described previously (8), using the conditions described above
for controlled CIV activity plus 2 M safranin.
Statistical analysis
Data were collected from three to ten mitochondrial prepa-
rations for each strain and expressed as mean  S.D. The sig-
nificance between measurements was determined by unpaired
Student t test using GraphPad Prism 8. Each experimental
group was compared only with the WT control and not with
other experimental groups. All p values lower than 0.05 were
considered statistically significant.
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